CVS launches biosimilar manufacturing subsidiary

By Becker's Hospital Review - Healthcare News in Becker's Hospital Review, Channels, Featured, ROOT, Static
August 24, 2023

CVS unveiled Cordavis, a new subsidiary focused on biosimilars in the U.S., on Aug. 23.

Read the full post on Becker's Hospital Review - Healthcare News

Becker's Hospital Review - Healthcare News